Posts in: press clippings (3)

Slack Capital interview: Damien Perriman, CCO
investorpress clippingsvideo
Slack Capital interview: Damien Perriman, CCOMay 20, 2025
Michael Heltzen & Erum Azeez Khan
heltzenpress releaseinvestorpress clippings
Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything'May 16, 2025
Tyler Korman
investorpress clippingsvideo
Slack Capital interview: Tyler Korman, VP of ResearchMay 15, 2025
Slack Capital: EXOZ investment report and CEO interview
heltzeninvestorpress clippingsvideo
Slack Capital: EXOZ investment report and CEO interviewMay 13, 2025
Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler Korman
investorpress clippingsvideoscience
Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler KormanApril 15, 2025
World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial Officer
investorpress clippings
World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial OfficerApril 3, 2025
Chemical Engineering: Enzyme engineering breaks out of the cell
press clippingsscience
Chemical Engineering: Enzyme engineering breaks out of the cellApril 1, 2025
Fox Business: Interview with Chief Market Strategist, Lou Basenese
investorpress clippingsvideo
Fox Business: Interview with Chief Market Strategist, Lou BaseneseMarch 17, 2025
ARCHIVE: Fox Business: Interview with CEO Michael Heltzen
heltzeninvestorpress clippingsvideoARCHIVE
ARCHIVE: Fox Business: Interview with CEO Michael HeltzenMarch 3, 2025
ARCHIVE: GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes
press clippingsARCHIVE
ARCHIVE: GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymesFebruary 15, 2025
Previous page
Page 3 of 4
Next page